A program to help Black sexual minority men cope with trauma after an HIV diagnosis
A Trauma-Informed Intervention for Sexual Minority Men Recently Diagnosed with HIV
This study is testing a new program called RISE to help Black men who have recently been diagnosed with HIV by providing support for stress and trauma, so they can feel better and stick to their treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10770718 on NIH RePORTER |
What this research studies
This research focuses on developing and testing a new intervention called RISE, designed specifically for Black sexual minority men who have recently been diagnosed with HIV. The program aims to address the high rates of trauma and stress-related disorders in this population, which can negatively impact their mental health and adherence to HIV treatment. By utilizing techniques from Cognitive-Behavior Therapy and Resilience Theory, RISE seeks to provide early mental health support to improve overall well-being and treatment outcomes. Participants will engage in resilience-focused activities that help them manage stress and trauma effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black sexual minority men who have recently been diagnosed with HIV and are experiencing trauma or stress-related symptoms.
Not a fit: Patients who are not Black sexual minority men or those who have not been recently diagnosed with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve mental health and treatment adherence among Black sexual minority men living with HIV.
How similar studies have performed: Previous research has shown that trauma-informed interventions can be effective in improving mental health outcomes for individuals living with HIV, suggesting a promising approach for this population.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Vincent, Wilson — Temple Univ of the Commonwealth
- Study coordinator: Vincent, Wilson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.